{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:39:44Z","timestamp":1707525584556},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,28]]},"DOI":"10.7759\/cureus.51211","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T10:19:45Z","timestamp":1703758785000},"source":"Crossref","is-referenced-by-count":0,"title":["The Differences in Clinical Manifestations and Prognosis of Infective Endocarditis Patients With Positive Serology to Antineutrophilic Cytoplasmic Antibody Compared to Negative Serology"],"prefix":"10.7759","author":[{"given":"David J","family":"Ozeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shani","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Brif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itai","family":"Gueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Oppenheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/2050312117741772","article-title":"A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a large tertiary-care teaching hospital","volume":"5","author":"Mostaghim AS","year":"2017","unstructured":"Mostaghim AS, Lo HY, Khardori N. A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a large tertiary-care teaching hospital. SAGE Open Med. 2017, 5:10.1177\/2050312117741772","journal-title":"SAGE Open Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.7596","article-title":"Management considerations in infective endocarditis","volume":"320","author":"Wang A","year":"2018","unstructured":"Wang A, Gaca JG, Chu VH. Management considerations in infective endocarditis. JAMA. 2018, 320:72-83. 10.1001\/jama.2018.7596","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003016","article-title":"Validated risk score for predicting 6-month mortality in infective endocarditis","volume":"5","author":"Park LP","year":"2016","unstructured":"Park LP, Chu VH, Peterson G, et al.. Validated risk score for predicting 6-month mortality in infective endocarditis. J Am Heart Assoc. 2016, 5:e003016. 10.1161\/JAHA.115.003016","journal-title":"J Am Heart Assoc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li JS","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, et al.. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000, 30:633-8. 10.1086\/313753","journal-title":"Clin Infect Dis"},{"key":"ref5","article-title":"Antineutrophil cytoplasmic antibodies","volume":"4","author":"Hoffman GS","year":"1998","unstructured":"Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis &amp; Rheumatism. 1998, 4:1529-37.","journal-title":"Arthritis & Rheumatism"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.47.1.303","article-title":"Antineutrophil cytoplasmic antibodies in the classification of vasculitis","volume":"47","author":"Niles JL","year":"1996","unstructured":"Niles JL. Antineutrophil cytoplasmic antibodies in the classification of vasculitis. Annu Rev Med. 1996, 47:303-13. 10.1146\/annurev.med.47.1.303","journal-title":"Annu Rev Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.020","article-title":"Infections and antineutrophil cytoplasmic antibodies: Triggering mechanisms","volume":"14","author":"Konstantinov KN","year":"2015","unstructured":"Konstantinov KN, Ulff-M\u00f8ller CJ, Tzamaloukas AH. Infections and antineutrophil cytoplasmic antibodies: Triggering mechanisms. Autoimmun Rev. 2015, 14:201-3. 10.1016\/j.autrev.2014.10.020","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1874","article-title":"Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis","volume":"14","author":"Kain R","year":"2008","unstructured":"Kain R, Exner M, Brandes R, et al.. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008, 14:1088-96. 10.1038\/nm.1874","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000165886.93427.b1","article-title":"New insights that link microbes with the generation of antineutrophil cytoplasmic autoantibodies: the theory of autoantigen complementarity","volume":"14","author":"Preston GA","year":"2005","unstructured":"Preston GA, Pendergraft WF 3rd, Falk RJ. New insights that link microbes with the generation of antineutrophil cytoplasmic autoantibodies: the theory of autoantigen complementarity. Curr Opin Nephrol Hypertens. 2005, 14:217-22. 10.1097\/01.mnh.0000165886.93427.b1","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-9-34","article-title":"CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis","volume":"9","author":"Hurtado PR","year":"2008","unstructured":"Hurtado PR, Jeffs L, Nitschke J, et al.. CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis. BMC Immunol. 2008, 9:34. 10.1186\/1471-2172-9-34","journal-title":"BMC Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40034","article-title":"Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis","volume":"120","author":"Ciavatta DJ","year":"2010","unstructured":"Ciavatta DJ, Yang J, Preston GA, et al.. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest vol. 120 3209-3219 Preprint at https:\/\/doi.org\/10.1172\/jci40034. 2010, 120:3209-19. 10.1172\/JCI40034","journal-title":"J Clin Invest vol. 120 3209-3219 Preprint at https:\/\/doi.org\/10.1172\/jci40034"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009060616","article-title":"LAMPs and NETs in the pathogenesis of ANCA vasculitis","volume":"20","author":"Bosch X","year":"2009","unstructured":"Bosch X. LAMPs and NETs in the pathogenesis of ANCA vasculitis. J Am Soc Nephrol. 2009, 20:1654-6. 10.1681\/ASN.2009060616","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<226::AID-ANR27>3.0.CO;2-Q","article-title":"Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies","volume":"43","author":"Choi HK","year":"2000","unstructured":"Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis &amp; Rheumatism vol. 43 226-231 Preprint at https:\/\/doi.org\/10.1002\/1529-0131. 2000, 43:226-31. 10.1002\/1529-0131(200001)43:1&lt;226::AID-ANR27&gt;3.0.CO;2-Q","journal-title":"Arthritis & Rheumatism vol. 43 226-231 Preprint at https:\/\/doi.org\/10.1002\/1529-0131"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.38389","article-title":"Brief report: Prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis","volume":"66","author":"Mahr A","year":"2014","unstructured":"Mahr A, Batteux F, Tubiana S, et al.. Brief report: Prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheumatol. 2014, 66:1672-7. 10.1002\/art.38389","journal-title":"Arthritis Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002564","article-title":"Antineutrophil cytoplasmic antibodies associated with infective endocarditis","volume":"95","author":"Langlois V","year":"2016","unstructured":"Langlois V, Lesourd A, Girszyn N, M\u00e9nard JF, Levesque H, Caron F, Marie I. Antineutrophil cytoplasmic antibodies associated with infective endocarditis. Medicine. 2016, 95:e2564. 10.1097\/MD.0000000000002564","journal-title":"Medicine"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.424","article-title":"Update on endocarditis-associated glomerulonephritis","volume":"87","author":"Boils CL","year":"2015","unstructured":"Boils CL, Nasr SH, Walker PD, Couser WG, Larsen CP. Update on endocarditis-associated glomerulonephritis. Kidney Int. 2015, 87:1241-9. 10.1038\/ki.2014.424","journal-title":"Kidney Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-1694-2","article-title":"Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: A case report and literature review","volume":"21","author":"Bele D","year":"2020","unstructured":"Bele D, Kojc N, Per\u0161e M, \u010cerne \u010cer\u010dek A, Lindi\u010d J, Ale\u0161 Rigler A, Ve\u010deri\u0107-Haler \u017d. Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: A case report and literature review. BMC Nephrol. 2020, 21:40. 10.1186\/s12882-020-1694-2","journal-title":"BMC Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching AR","year":"2020","unstructured":"Kitching AR, Anders HJ, Basu N, et al.. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020, 6:71. 10.1038\/s41572-020-0204-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4110\/in.2014.14.1.7","article-title":"Potential role of bacterial infection in autoimmune diseases: A new aspect of molecular mimicry","volume":"14","author":"Alam J","year":"2014","unstructured":"Alam J, Kim YC, Choi Y. Potential role of bacterial infection in autoimmune diseases: A new aspect of molecular mimicry. Immune Netw. 2014, 14:7-13. 10.4110\/in.2014.14.1.7","journal-title":"Immune Netw"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/195024-the-differences-in-clinical-manifestations-and-prognosis-of-infective-endocarditis-patients-with-positive-serology-to-antineutrophilic-cytoplasmic-antibody-compared-to-negative-serology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:41Z","timestamp":1707509501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/195024-the-differences-in-clinical-manifestations-and-prognosis-of-infective-endocarditis-patients-with-positive-serology-to-antineutrophilic-cytoplasmic-antibody-compared-to-negative-serology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.51211","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,28]]}}}